Advances have been made in the field of nonalcoholic fatty liver disease in 2019. One paper highlights the role of gut microbiota in hepatocellular carcinoma (HCC) pathogenesis, another presents a noninvasive algorithm for detecting advanced liver fibrosis and another suggests a potential novel approach to treating nonalcoholic steatohepatitis and suppressing HCC development.
What's new in NAFLD pathogenesis, biomarkers and treatment?
Targher, GiovanniWriting – Original Draft Preparation
2020-01-01
Abstract
Advances have been made in the field of nonalcoholic fatty liver disease in 2019. One paper highlights the role of gut microbiota in hepatocellular carcinoma (HCC) pathogenesis, another presents a noninvasive algorithm for detecting advanced liver fibrosis and another suggests a potential novel approach to treating nonalcoholic steatohepatitis and suppressing HCC development.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Targher Whats a new in NAFLD.pdf
solo utenti autorizzati
Descrizione: What's new in NAFLD pathogenesis, biomarkers and treatment?
Tipologia:
Versione dell'editore
Licenza:
Accesso ristretto
Dimensione
1.41 MB
Formato
Adobe PDF
|
1.41 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
